Crossmark

Metathramycin, a new bioactive aureolic acid discovered by heterologous expression of a metagenome derived biosynthetic pathway

Crossref DOI link: https://doi.org/10.1039/D0CB00228C

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Stevenson, Luke J. https://orcid.org/0000-0002-1130-2747
Bracegirdle, Joe https://orcid.org/0000-0001-7725-3477
Liu, Liwei

Sharrock, Abigail V. https://orcid.org/0000-0003-2837-9481
Ackerley, David F. https://orcid.org/0000-0002-6188-9902
Keyzers, Robert A. https://orcid.org/0000-0002-7658-7421
Owen, Jeremy G. https://orcid.org/0000-0003-4738-6628
Funding

Funding for this research was provided by:

Ministry of Business, Innovation and Employment (RTVU1908)

Health Research Council of New Zealand (16/172)

Royal Society of New Zealand (RDF-VUW1601)
License Information

Version of Record valid from 2021-02-02
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Luke J. Stevenson (ORCID)

: Joe Bracegirdle (ORCID)

: Abigail V. Sharrock (ORCID)

: David F. Ackerley (ORCID)

: Robert A. Keyzers (ORCID)

: Jeremy G. Owen (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 8 December 2020; Accepted 21 January 2021; Advance Article published 2 February 2021; Version of Record published 15 April 2021